Available online at: (Accessed September 30, 2015)
It is not approved for human or veterinary use, and no therapeutic or performance claims are made for this formulation
Morbidity improvements are generally lower than mortality improvements due to a higher proportion of morbidity incidence (in a critical illness product) being caused by cancers (where the relative risks of incidence by BMI are lower), compared to mortality, with a higher proportion of deaths caused by CVD (where the relative risks by BMI are higher)
The current evidence suggests that Rybelsus has not shown a signal for direct liver toxicity in most patients
Who might be a good candidate for a GLP-1 GLP-1 medications arent right for everyone, but they may be worth discussing with your healthcare provider if: You have PCOS and insulin resistance or prediabetes You have a BMI of 30+, or 27+ with other health risks Youve tried lifestyle changes and medications like metformin without success Youre not currently trying to conceive or pregnant GLP-1s are not recommended if youre pregnant, breastfeeding, or have a history of specific thyroid or endocrine cancers, or pancreatitis